BNTC Stock Analysis: Buy, Sell, or Hold?
BNTC - Benitec Biopharma Inc. Common Stock
$12.88
0.58 (4.72%)
▲
5d:
+13.68%
30d:
+13.38%
90d:
+15.1%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When BNTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: BNTC is 9.1% above its trading range ($11.81). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: BNTC is 9.1% above its trading range ($11.81). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: BNTC is currently trading at $12.88, which is considered extended relative to its 30-day fair value range of $10.61 to $11.81.
Technical Outlook: Technically, BNTC is showing sideways momentum. The price is approaching resistance at $13.23. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.7% recently.
Market Sentiment: BNTC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $25.80 (+100.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BNTC is showing sideways momentum. The price is approaching resistance at $13.23. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.7% recently.
Market Sentiment: BNTC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $25.80 (+100.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$10.61 -
$11.81
Company Quality Score
54/100
(HOLD)
Options IV Signal
32th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
64.6%
All Signals
- BEARISH: Price extended above range (+9.1% above its trading range)
- NEUTRAL: Options fairly priced (IV 32th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.7%)
- BULLISH: Trading 100.3% below Wall St target ($25.80)
- CAUTION: Extended 9.1% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$10.61 -
$11.81
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$1.71
(13.2%)
Support & Resistance Levels
Support Level
$10.00
Resistance Level
$13.23
Current Trend
Sideways
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.23
Wall Street Target
$25.80
(+100.3%)
Revenue Growth (YoY)
12.5%
Share & Embed Analysis
Last updated: June 24, 2026 1:04 AM ET
Data refreshes hourly during market hours. Next update: 2:04 AM
Data refreshes hourly during market hours. Next update: 2:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BNTC showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Suvretta Capital Managem…
BUY
77387 shares
2025-12-29
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 65 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 54 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 67 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 52 HOLD |
